European equities aren't getting a loud bull or bear call in this week's published research — the message is more nuanced.
On the FTSE 100, one strand of recent analysis frames UK equities less as a top-return bet and more as a diversifier. The argument: the index's heavy tilt toward Energy and Consumer Staples offers a useful counterweight to markets dominated by AI-linked names, even if long-run returns may lag. No directional price target was attached.
On single stocks, a separate technical read on German-listed Redcare Pharmacy points the other way. Researchers note the shares have been in a primary downtrend since hitting a multi-year low near €30.20 in March, but a dynamic multi-week recovery rally since then may be laying the groundwork for a broader bottom. The view is explicitly hedged, based on chart patterns, and comes with no stated time horizon.
Net-net: the published European equity commentary this cycle is about portfolio role and tentative technical repair — not conviction calls.